APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Zoster Vaccine Live

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Zoster Vaccine Live Industry Growth and Trends Forecast to 2032

Report ID 174048960119 December 202573 pages

Choose your research edition.

Industry ResearchZoster Vaccine Live Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Zoster Vaccine Live Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Zoster Vaccine Live Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Zoster Vaccine Live Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Zoster Vaccine Live Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Zoster Vaccine Live market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Zoster Vaccine Live is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Zoster Vaccine Live is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Zoster Vaccine Live is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Zoster Vaccine Live include Merck and GSK among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Zoster Vaccine Live market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Zoster Vaccine Live market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Zoster Vaccine Live market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Zoster Vaccine Live.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Zoster Vaccine Live market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Zoster Vaccine Live Market by Company

Merck

GSK

Zoster Vaccine Live Segment by Type

Monovalent Vaccine

Combination Vaccine

Zoster Vaccine Live Segment by Application

Kids Injection

Adults Injection

Zoster Vaccine Live Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zoster Vaccine Live market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Zoster Vaccine Live and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zoster Vaccine Live.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Zoster Vaccine Live manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Zoster Vaccine Live in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Monovalent Vaccine Table 2. Major Company of Combination Vaccine Table 3. Global Zoster Vaccine Live Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Zoster Vaccine Live Sales by Type (2021-2026) & (K Units) Table 5. Global Zoster Vaccine Live Sales Market Share in Volume by Type (2021-2026) Table 6. Global Zoster Vaccine Live Sales by Type (2021-2026) & (US$ Million) Table 7. Global Zoster Vaccine Live Sales Market Share in Value by Type (2021-2026) Table 8. Global Zoster Vaccine Live Price by Type (2021-2026) & (US$/Unit) Table 9. Global Zoster Vaccine Live Sales by Type (2027-2032) & (K Units) Table 10. Global Zoster Vaccine Live Sales Market Share in Volume by Type (2027-2032) Table 11. Global Zoster Vaccine Live Sales by Type (2027-2032) & (US$ Million) Table 12. Global Zoster Vaccine Live Sales Market Share in Value by Type (2027-2032) Table 13. Global Zoster Vaccine Live Price by Type (2027-2032) & (US$/Unit) Table 14. North America Zoster Vaccine Live Sales by Type (2021-2026) & (K Units) Table 15. North America Zoster Vaccine Live Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Zoster Vaccine Live Sales by Type (2021-2026) & (K Units) Table 17. Europe Zoster Vaccine Live Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Zoster Vaccine Live Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Zoster Vaccine Live Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Zoster Vaccine Live Sales by Type (2021-2026) & (K Units) Table 21. Latin America Zoster Vaccine Live Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Zoster Vaccine Live Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Zoster Vaccine Live Sales by Type (2021-2026) & (US$ Million) Table 24. Zoster Vaccine Live Industry Trends Table 25. Zoster Vaccine Live Industry Drivers Table 26. Zoster Vaccine Live Industry Opportunities and Challenges Table 27. Zoster Vaccine Live Industry Restraints Table 28. Global Zoster Vaccine Live Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Zoster Vaccine Live Revenue Market Share by Company (2021-2026) Table 30. Global Zoster Vaccine Live Sales by Company (2021-2026) & (K Units) Table 31. Global Zoster Vaccine Live Sales Share by Company (2021-2026) Table 32. Global Zoster Vaccine Live Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Zoster Vaccine Live Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Zoster Vaccine Live Major Company Production Sites and Headquarters Table 35. Global Zoster Vaccine Live Company, Product Type & Application Table 36. Global Zoster Vaccine Live Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Zoster Vaccine Live by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Zoster Vaccine Live Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Zoster Vaccine Live Sales by Region (2021-2026) & (K Units) Table 41. Global Zoster Vaccine Live Sales Market Share in Volume by Region (2021-2026) Table 42. Global Zoster Vaccine Live Sales by Region (2021-2026) & (US$ Million) Table 43. Global Zoster Vaccine Live Sales Market Share in Value by Region (2021-2026) Table 44. Global Zoster Vaccine Live Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Zoster Vaccine Live Sales by Region (2027-2032) & (K Units) Table 46. Global Zoster Vaccine Live Sales Market Share in Volume by Region (2027-2032) Table 47. Global Zoster Vaccine Live Sales by Region (2027-2032) & (US$ Million) Table 48. Global Zoster Vaccine Live Sales Market Share in Value by Region (2027-2032) Table 49. Global Zoster Vaccine Live Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Zoster Vaccine Live Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Zoster Vaccine Live Sales by Application (2021-2026) & (K Units) Table 52. Global Zoster Vaccine Live Sales Market Share in Volume by Application (2021-2026) Table 53. Global Zoster Vaccine Live Sales by Application (2021-2026) & (US$ Million) Table 54. Global Zoster Vaccine Live Sales Market Share in Value by Application (2021-2026) Table 55. Global Zoster Vaccine Live Price by Application (2021-2026) & (US$/Unit) Table 56. Global Zoster Vaccine Live Sales by Application (2027-2032) & (K Units) Table 57. Global Zoster Vaccine Live Sales Market Share in Volume by Application (2027-2032) Table 58. Global Zoster Vaccine Live Sales by Application (2027-2032) & (US$ Million) Table 59. Global Zoster Vaccine Live Sales Market Share in Value by Application (2027-2032) Table 60. Global Zoster Vaccine Live Price by Application (2027-2032) & (US$/Unit) Table 61. North America Zoster Vaccine Live Sales by Application (2021-2026) & (K Units) Table 62. North America Zoster Vaccine Live Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Zoster Vaccine Live Sales by Application (2021-2026) & (K Units) Table 64. Europe Zoster Vaccine Live Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Zoster Vaccine Live Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Zoster Vaccine Live Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Zoster Vaccine Live Sales by Application (2021-2026) & (K Units) Table 68. Latin America Zoster Vaccine Live Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Zoster Vaccine Live Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Zoster Vaccine Live Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Zoster Vaccine Live Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Merck Zoster Vaccine Live Product Portfolio Table 75. Merck Recent Development Table 76. GSK Company Information Table 77. GSK Business Overview Table 78. GSK Zoster Vaccine Live Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. GSK Zoster Vaccine Live Product Portfolio Table 80. GSK Recent Development Table 81. North America Zoster Vaccine Live Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 82. North America Zoster Vaccine Live Sales by Country (2021-2026) & (K Units) Table 83. North America Zoster Vaccine Live Sales Market Share by Country (2021-2026) Table 84. North America Zoster Vaccine Live Sales Forecast by Country (2027-2032) & (K Units) Table 85. North America Zoster Vaccine Live Sales Market Share Forecast by Country (2027-2032) Table 86. North America Zoster Vaccine Live Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 87. North America Zoster Vaccine Live Market Size by Country (2021-2026) & (US$ Million) Table 88. North America Zoster Vaccine Live Market Share by Country (2021-2026) Table 89. North America Zoster Vaccine Live Market Size Forecast by Country (2027-2032) & (US$ Million) Table 90. North America Zoster Vaccine Live Market Share Forecast by Country (2027-2032) Table 91. Europe Zoster Vaccine Live Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. Europe Zoster Vaccine Live Sales by Country (2021-2026) & (K Units) Table 93. Europe Zoster Vaccine Live Sales Market Share by Country (2021-2026) Table 94. Europe Zoster Vaccine Live Sales Forecast by Country (2027-2032) & (K Units) Table 95. Europe Zoster Vaccine Live Sales Market Share Forecast by Country (2027-2032) Table 96. Europe Zoster Vaccine Live Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. Europe Zoster Vaccine Live Market Size by Country (2021-2026) & (US$ Million) Table 98. Europe Zoster Vaccine Live Market Share by Country (2021-2026) Table 99. Europe Zoster Vaccine Live Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. Europe Zoster Vaccine Live Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Zoster Vaccine Live Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Zoster Vaccine Live Sales by Country (2021-2026) & (K Units) Table 103. Asia-Pacific Zoster Vaccine Live Sales Market Share by Country (2021-2026) Table 104. Asia-Pacific Zoster Vaccine Live Sales Forecast by Country (2027-2032) & (K Units) Table 105. Asia-Pacific Zoster Vaccine Live Sales Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Zoster Vaccine Live Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Zoster Vaccine Live Market Size by Country (2021-2026) & (US$ Million) Table 108. Asia-Pacific Zoster Vaccine Live Market Share by Country (2021-2026) Table 109. Asia-Pacific Zoster Vaccine Live Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Asia-Pacific Zoster Vaccine Live Market Share Forecast by Country (2027-2032) Table 111. Latin America Zoster Vaccine Live Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Latin America Zoster Vaccine Live Sales by Country (2021-2026) & (K Units) Table 113. Latin America Zoster Vaccine Live Sales Market Share by Country (2021-2026) Table 114. Latin America Zoster Vaccine Live Sales Forecast by Country (2027-2032) & (K Units) Table 115. Latin America Zoster Vaccine Live Sales Market Share Forecast by Country (2027-2032) Table 116. Latin America Zoster Vaccine Live Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Latin America Zoster Vaccine Live Market Size by Country (2021-2026) & (US$ Million) Table 118. Latin America Zoster Vaccine Live Market Share by Country (2021-2026) Table 119. Latin America Zoster Vaccine Live Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Latin America Zoster Vaccine Live Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Zoster Vaccine Live Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Zoster Vaccine Live Sales by Country (2021-2026) & (K Units) Table 123. Middle East and Africa Zoster Vaccine Live Sales Market Share by Country (2021-2026) Table 124. Middle East and Africa Zoster Vaccine Live Sales Forecast by Country (2027-2032) & (K Units) Table 125. Middle East and Africa Zoster Vaccine Live Sales Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Zoster Vaccine Live Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Zoster Vaccine Live Market Size by Country (2021-2026) & (US$ Million) Table 128. Middle East and Africa Zoster Vaccine Live Market Share by Country (2021-2026) Table 129. Middle East and Africa Zoster Vaccine Live Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Middle East and Africa Zoster Vaccine Live Market Share Forecast by Country (2027-2032) Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Zoster Vaccine Live Distributors List Table 134. Zoster Vaccine Live Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Zoster Vaccine Live Image Figure 2. Global Zoster Vaccine Live Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Zoster Vaccine Live Market Size (2021-2032) & (US$ Million) Figure 4. Global Zoster Vaccine Live Sales (2021-2032) & (K Units) Figure 5. Monovalent Vaccine Image Figure 6. Global Monovalent Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Combination Vaccine Image Figure 8. Global Combination Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Zoster Vaccine Live Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Zoster Vaccine Live Market Share by Type 2025 VS 2032 Figure 11. North America Zoster Vaccine Live Sales Market Share in Volume by Type in 2025 Figure 12. North America Zoster Vaccine Live Sales Market Share in Value by Type in 2025 Figure 13. Europe Zoster Vaccine Live Sales Market Share in Volume by Type in 2025 Figure 14. Europe Zoster Vaccine Live Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Zoster Vaccine Live Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Zoster Vaccine Live Sales Market Share in Value by Type in 2025 Figure 17. Latin America Zoster Vaccine Live Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Zoster Vaccine Live Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Zoster Vaccine Live Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Zoster Vaccine Live Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Zoster Vaccine Live Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Kids Injection Image Figure 24. Global Kids Injection Sales YoY Growth (2021-2032) & (K Units) Figure 25. Adults Injection Image Figure 26. Global Adults Injection Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Zoster Vaccine Live Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Zoster Vaccine Live Market Share by Application 2025 VS 2032 Figure 29. North America Zoster Vaccine Live Sales Market Share in Volume by Application in 2025 Figure 30. North America Zoster Vaccine Live Sales Market Share in Value by Application in 2025 Figure 31. Europe Zoster Vaccine Live Sales Market Share in Volume by Application in 2025 Figure 32. Europe Zoster Vaccine Live Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Zoster Vaccine Live Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Zoster Vaccine Live Sales Market Share in Value by Application in 2025 Figure 35. Latin America Zoster Vaccine Live Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Zoster Vaccine Live Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Zoster Vaccine Live Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Zoster Vaccine Live Sales Market Share in Value by Application in 2025 Figure 39. North America Zoster Vaccine Live Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Zoster Vaccine Live Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Zoster Vaccine Live Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Zoster Vaccine Live Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Zoster Vaccine Live Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Zoster Vaccine Live Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Zoster Vaccine Live Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Zoster Vaccine Live Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Zoster Vaccine Live Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Zoster Vaccine Live Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Zoster Vaccine Live Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Zoster Vaccine Live Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Zoster Vaccine Live Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Zoster Vaccine Live Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Zoster Vaccine Live Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Zoster Vaccine Live Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Zoster Vaccine Live Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Zoster Vaccine Live Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Zoster Vaccine Live Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Zoster Vaccine Live Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Zoster Vaccine Live Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Zoster Vaccine Live Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccine
  • Combination Vaccine
Applications
  • Kids Injection
  • Adults Injection
Companies covered
  • Merck
  • GSK

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Zoster Vaccine Live Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Zoster Vaccine Live Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Zoster Vaccine Live Market by Type
  6. 1.3.1 Monovalent Vaccine
  7. 1.3.2 Combination Vaccine
  8. 1.4 Global Zoster Vaccine Live Market Size by Type
  9. 1.4.1 Global Zoster Vaccine Live Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Zoster Vaccine Live Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Zoster Vaccine Live Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Zoster Vaccine Live Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Zoster Vaccine Live Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Zoster Vaccine Live Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Zoster Vaccine Live Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Zoster Vaccine Live Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Zoster Vaccine Live Industry Trends
  2. 2.2 Zoster Vaccine Live Industry Drivers
  3. 2.3 Zoster Vaccine Live Industry Opportunities and Challenges
  4. 2.4 Zoster Vaccine Live Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Zoster Vaccine Live Revenue (2021-2026)
  2. 3.2 Global Top Players by Zoster Vaccine Live Sales (2021-2026)
  3. 3.3 Global Top Players by Zoster Vaccine Live Price (2021-2026)
  4. 3.4 Global Zoster Vaccine Live Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Zoster Vaccine Live Major Company Production Sites & Headquarters
  6. 3.6 Global Zoster Vaccine Live Company, Product Type & Application
  7. 3.7 Global Zoster Vaccine Live Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Zoster Vaccine Live Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Zoster Vaccine Live Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Zoster Vaccine Live Tier 1, Tier 2, and Tier 3
4 Zoster Vaccine Live Regional Status and Outlook
  1. 4.1 Global Zoster Vaccine Live Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Zoster Vaccine Live Historic Market Size by Region
  3. 4.2.1 Global Zoster Vaccine Live Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Zoster Vaccine Live Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Zoster Vaccine Live Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Zoster Vaccine Live Forecasted Market Size by Region
  7. 4.3.1 Global Zoster Vaccine Live Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Zoster Vaccine Live Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Zoster Vaccine Live Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Zoster Vaccine Live by Application
  1. 5.1 Zoster Vaccine Live Market by Application
  2. 5.1.1 Kids Injection
  3. 5.1.2 Adults Injection
  4. 5.2 Global Zoster Vaccine Live Market Size by Application
  5. 5.2.1 Global Zoster Vaccine Live Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Zoster Vaccine Live Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Zoster Vaccine Live Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Zoster Vaccine Live Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Zoster Vaccine Live Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Zoster Vaccine Live Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Zoster Vaccine Live Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Zoster Vaccine Live Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Zoster Vaccine Live Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Zoster Vaccine Live Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK Zoster Vaccine Live Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK Zoster Vaccine Live Product Portfolio
  12. 6.2.5 GSK Recent Developments
7 North America by Country
  1. 7.1 North America Zoster Vaccine Live Sales by Country
  2. 7.1.1 North America Zoster Vaccine Live Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Zoster Vaccine Live Sales by Country (2021-2026)
  4. 7.1.3 North America Zoster Vaccine Live Sales Forecast by Country (2027-2032)
  5. 7.2 North America Zoster Vaccine Live Market Size by Country
  6. 7.2.1 North America Zoster Vaccine Live Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Zoster Vaccine Live Market Size by Country (2021-2026)
  8. 7.2.3 North America Zoster Vaccine Live Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Zoster Vaccine Live Sales by Country
  2. 8.1.1 Europe Zoster Vaccine Live Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Zoster Vaccine Live Sales by Country (2021-2026)
  4. 8.1.3 Europe Zoster Vaccine Live Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Zoster Vaccine Live Market Size by Country
  6. 8.2.1 Europe Zoster Vaccine Live Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Zoster Vaccine Live Market Size by Country (2021-2026)
  8. 8.2.3 Europe Zoster Vaccine Live Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Zoster Vaccine Live Sales by Country
  2. 9.1.1 Asia-Pacific Zoster Vaccine Live Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Zoster Vaccine Live Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Zoster Vaccine Live Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Zoster Vaccine Live Market Size by Country
  6. 9.2.1 Asia-Pacific Zoster Vaccine Live Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Zoster Vaccine Live Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Zoster Vaccine Live Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Zoster Vaccine Live Sales by Country
  2. 10.1.1 South America Zoster Vaccine Live Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Zoster Vaccine Live Sales by Country (2021-2026)
  4. 10.1.3 South America Zoster Vaccine Live Sales Forecast by Country (2027-2032)
  5. 10.2 South America Zoster Vaccine Live Market Size by Country
  6. 10.2.1 South America Zoster Vaccine Live Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Zoster Vaccine Live Market Size by Country (2021-2026)
  8. 10.2.3 South America Zoster Vaccine Live Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Zoster Vaccine Live Sales by Country
  2. 11.1.1 Middle East and Africa Zoster Vaccine Live Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Zoster Vaccine Live Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Zoster Vaccine Live Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Zoster Vaccine Live Market Size by Country
  6. 11.2.1 Middle East and Africa Zoster Vaccine Live Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Zoster Vaccine Live Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Zoster Vaccine Live Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Zoster Vaccine Live Value Chain Analysis
  2. 12.1.1 Zoster Vaccine Live Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Zoster Vaccine Live Production Mode & Process
  7. 12.2 Zoster Vaccine Live Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Zoster Vaccine Live Distributors
  10. 12.2.3 Zoster Vaccine Live Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst